Literature DB >> 17519123

How to treat hypertension in patients with peripheral artery disease.

Denis L Clement1, Marc L Debuyzere.   

Abstract

The risk of peripheral artery disease is underestimated by many physicians; such risk is further augmented by the presence of hypertension. Detection of these conditions is essential to prevent cardiovascular accidents. This review deals with the management of peripheral artery disease as a risk factor, highlighting the need for triple therapy (antiplatelet drugs, angiotensin-converting enzyme inhibitors, and statins). Treatment of hypertension is approached by reviewing the essentials of the different antihypertensive drugs available, focusing on their peripheral circulatory effect. However, because individual antihypertensive drugs seem not to differ largely in this respect, attention is drawn to the message that the most important task in these patients is to control total cardiovascular risk rather than focusing on the choice of the individual antihypertensive drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17519123     DOI: 10.1007/s11906-007-0034-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   4.592


  33 in total

Review 1.  A clinical approach to the management of the patient with coronary (Co) and/or carotid (Ca) artery disease who presents with leg ischaemia (Lis).

Authors:  D L Clement; H Boccalon; J Dormandy; I Durand-Zaleski; G Fowkes; T Brown
Journal:  Int Angiol       Date:  2000-06       Impact factor: 2.789

2.  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Authors:  Björn Dahlöf; Peter S Sever; Neil R Poulter; Hans Wedel; D Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

3.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

Authors:  B Neal; S MacMahon; N Chapman
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

4.  Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials.

Authors:  Sorin J Brener; Thomas B Ivanc; Roman Poliszczuk; Michael Chen; E Murat Tuzcu; Tingfei Hu; David J Frid; Steven E Nissen
Journal:  Am Heart J       Date:  2006-12       Impact factor: 4.749

5.  Effect of beta-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease.

Authors:  W R Hiatt; S Stoll; A S Nies
Journal:  Circulation       Date:  1985-12       Impact factor: 29.690

6.  Temporal trends in the incidence of intermittent claudication from 1950 to 1999.

Authors:  Joanne M Murabito; Jane C Evans; Ralph B D'Agostino; Peter W F Wilson; William B Kannel
Journal:  Am J Epidemiol       Date:  2005-08-02       Impact factor: 4.897

7.  Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease.

Authors:  Harm H H Feringa; Virginie H van Waning; Jeroen J Bax; Abdou Elhendy; Eric Boersma; Olaf Schouten; Wael Galal; Radosav V Vidakovic; Marco J Tangelder; Don Poldermans
Journal:  J Am Coll Cardiol       Date:  2006-02-23       Impact factor: 24.094

Review 8.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.

Authors:  Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-03-21       Impact factor: 29.690

9.  Effect of felodipine and metoprolol on muscle and skin arteries in hypertensive patients.

Authors:  D L Clement; N Y De Pue
Journal:  Drugs       Date:  1985       Impact factor: 9.546

10.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

View more
  3 in total

Review 1.  Treatment of hypertension in patients with peripheral arterial disease: an update.

Authors:  Denis L Clement
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 5.369

Review 2.  Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data.

Authors:  T De Backer; R Vander Stichele; P Lehert; L Van Bortel
Journal:  BMJ       Date:  2009-03-10

3.  Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials.

Authors:  Diana Thomas Manapurathe; Smriti Murali Krishna; Brittany Dewdney; Joseph Vaughan Moxon; Erik Biros; Jonathan Golledge
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.